Brilacidin
Brilacidin
Also known as: PMX-30063, Defensin Mimetic, Host Defense Peptide Mimetic
Overview
Key Facts
Primary Goal: A synthetic small-molecule mimetic of human host defense peptides (defensins)
A synthetic small-molecule mimetic of human host defense peptides (defensins). Designed to replicate the antimicrobial and immunomodulatory functions of natural defensins while offering improved stability and pharmacokinetics over native peptides. Half-Life ~8 hours Typical Dose 0.6–1.2 mg Frequency 1x daily Cycle Length 7-14 days (acute infection), longer for chronic use
Dosing Information
Half-Life
~8 hours
Typical Dose
0.6–1.2 mg
Frequency
1x daily
Cycle Length
7-14 days (acute infection), longer for chronic use
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Developed by Innovation Pharmaceuticals (formerly Cellceutix). Completed Phase 2 clinical trials for acute bacterial skin and skin structure infections (ABSSSI) with positive results. Also studied for oral mucositis and inflammatory bowel disease. Investigated as potential COVID-19 therapeutic. Represents a novel class of non-peptide immune defense mimetics.
Frequently Asked Questions
Common questions about Brilacidin
UK-Specific Information
Exclusive data points and guidance for UK residents using Brilacidin
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.